RespireRx Pharmaceuticals Inc. announce that Mr. Timothy Jones has joined the Company as its President and Chief Executive Officer. Mr. Jones has been a member of the Company's Board of Directors since January 28, 2020. Dr. Arnold Lippa, who has been serving as the Company's Interim CEO and Interim President, will cease to serve in those capacities, but will continue to serve as the Company's Executive Chairman and Chief Scientific Officer.

Mr. Jones joined the Company's board of directors on January 28, 2020. Mr. Jones is a highly experienced senior executive with a proven and outstanding track record in global commercial business development, specializing in developing and sustaining high value strategic and tactical partnerships.